MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 247 filers reported holding MIRATI THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $1,986,000 | -32.7% | 12,292 | -28.6% | 0.00% | -40.0% |
Q1 2021 | $2,951,000 | -34.5% | 17,225 | -16.0% | 0.01% | -37.5% |
Q4 2020 | $4,502,000 | +112.7% | 20,495 | +60.7% | 0.01% | +100.0% |
Q3 2020 | $2,117,000 | +14.4% | 12,750 | -21.4% | 0.00% | +33.3% |
Q2 2020 | $1,851,000 | +58.2% | 16,213 | +6.5% | 0.00% | +50.0% |
Q1 2020 | $1,170,000 | -33.6% | 15,220 | +11.4% | 0.00% | 0.0% |
Q4 2019 | $1,761,000 | +89.4% | 13,664 | +14.4% | 0.00% | +100.0% |
Q3 2019 | $930,000 | -28.4% | 11,939 | -5.3% | 0.00% | 0.0% |
Q2 2019 | $1,299,000 | +11.6% | 12,612 | -20.6% | 0.00% | 0.0% |
Q1 2019 | $1,164,000 | -63.0% | 15,875 | -78.6% | 0.00% | -75.0% |
Q4 2018 | $3,148,000 | -23.5% | 74,211 | -15.1% | 0.00% | 0.0% |
Q3 2018 | $4,117,000 | +57.8% | 87,420 | +65.2% | 0.00% | +33.3% |
Q2 2018 | $2,609,000 | +2589.7% | 52,919 | +100.0% | 0.00% | – |
Q2 2017 | $97,000 | -29.7% | 26,464 | 0.0% | 0.00% | – |
Q1 2017 | $138,000 | -49.3% | 26,464 | -53.8% | 0.00% | – |
Q4 2016 | $272,000 | -41.6% | 57,337 | -18.7% | 0.00% | -100.0% |
Q3 2016 | $466,000 | +88.7% | 70,532 | +512.0% | 0.00% | – |
Q1 2016 | $247,000 | -39.5% | 11,525 | -10.6% | 0.00% | -100.0% |
Q4 2015 | $408,000 | -10.7% | 12,892 | -2.9% | 0.00% | 0.0% |
Q3 2015 | $457,000 | +16.6% | 13,281 | +6.7% | 0.00% | 0.0% |
Q2 2015 | $392,000 | – | 12,451 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $116,595,216 | 81.37% |
ORACLE INVESTMENT MANAGEMENT INC | 201,400 | $7,488,052 | 7.25% |
Paradigm Biocapital Advisors LP | 1,396,779 | $51,932,243 | 4.92% |
Octagon Capital Advisors LP | 750,000 | $27,885,000 | 4.01% |
Boxer Capital, LLC | 2,000,000 | $74,360 | 3.65% |
Artal Group S.A. | 1,537,709 | $57,172 | 3.40% |
Avoro Capital Advisors LLC | 5,555,555 | $206,555,535 | 3.06% |
RTW INVESTMENTS, LP | 3,643,114 | $135,450,979 | 2.82% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 244,000 | $9,071,920 | 2.53% |
Kynam Capital Management, LP | 499,853 | $18,584,535 | 2.40% |